Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Merck

Skin cancer vaccine trial shows promising results

Moderna and Merck team up in new study.

Fortune

Dow Jones Rallies; Elon Musk Loses This Title As Tesla Tumbles; Bitcoin Up Amid Sam Bankman-Fried Arrest

The Dow Jones moved higher. Tesla CEO Elon Musk lost a famous title. Bitcoin rose after the Sam Bankman-Fried arrest. Moderna stock jumped.

Investors Business Daily

What the Moderna Cancer Vaccine News Doesn't Mean

Moderna and Merck hailed preliminary results from a combination therapy as a breakthrough, but there are important nuances to consider.

The Street

From analysis to the latest developments in health,
read the most diverse news in one place.

Researchers from Moderna and Merck just made a breakthrough with a skin cancer vaccine

Thank you, science.

Mic

Stock Market Rally, New Breakouts Fade At Midday As CPI Enthusiasm Wanes

The stock market's reaction to the inflation data was swift and decisive.

Investors Business Daily

Merck, Moderna detail potential skin cancer vaccine progress

Shares of Merck and Moderna jumped early Tuesday after the drugmakers said a potential skin cancer vaccine they are developing using the same technology behind COVID-19 preventive shots did well in a mid-stage study

The Independent UK

Moderna Stock Breaks Out As Cancer Vaccine Shows Promise In Keytruda Tie-Up

Moderna unveiled promising results for its personalized cancer vaccine on Tuesday. The results sent Moderna shares soaring.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Indonesia to produce Merck's HPV vaccines to combat cervical cancer

Indonesia will produce drugmaker Merck Co's vaccines for human papillomavirus (HPV), the chief of its state-owned pharmaceutical company Bio Farma said on Tuesday, in a bid to combat HPV-linked cervical cancer in the country.

Reuters

Mirati Wins FDA Approval For Amgen-Rivaling Cancer Drug As Wild Stock Swing Continues

The Food and Drug Administration approved Mirati's rival to Amgen's lung cancer drug, sending MRTX stock higher on Tuesday.

Investors Business Daily

Hot Fund To SEC: We're Boosting Bets On Best Stock Picks

Wondering how to invest in stocks and mutual funds amid a grim market? Red-hot Invesco Comstock Select Fund is doubling down on its strategy.

Investors Business Daily

3 Stocks Insiders Can’t Stop Buying This Month

After signs of cooling inflation, investors are hopeful that the Fed will slow its rate hikes over the coming months. With surging optimism, fundamentally strong stocks Merck (MRK), Coca-Cola (KO), and Verizon (VZ), which have seen increased insider buying, might be ideal investments now. Continue reading.

StockNews.com

Mirati Therapeutics Surges As Big Pharma Reportedly Preps For A Buyout Battle

Big Pharma suitors could be looking to buy Mirati Therapeutics, according to reports that sent MRTX stock close to a breakout Wednesday.

Investors Business Daily

See Why Gilead's Cancer Business Is Driving The Stock To A Fever Pitch

Gilead Sciences' first-in-class cancer drug and GILD stock are finally hitting their stride. The oncology business is growing bullishly.

Investors Business Daily

Imago BioSciences Catapults To Record High On Merck's $1.35 Billion Buyout

Biotech stock Imago BioSciences broke out and hit a record high Monday after Merck pledged to buy it for $1.35 billion.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Surges 900 Points On Cool Inflation Data; Treasury Yields Dive

The Dow Jones Industrial Average surged 900 points Thursday on cool inflation data, with the consumer price index (CPI) coming in lower than expected.

WEKU

Uganda ends school year early as it tries to contain growing Ebola outbreak

Since the outbreak began in September, eight children have died — and there is no approved vaccine. But doctors are hopeful that public health measures may be enough to stop the spread.

Investors Business Daily

Dow Jones Falls After Early Election Results; Elon Musk Sells More Tesla Stock

The Dow Jones Industrial Average fell Wednesday after U.S. election results. Tesla stock dropped after Elon Musk sold more Tesla shares.

Investors Business Daily

Dow Jones Rises On Election Day; Nvidia Jumps On New Chip For China

The Dow Jones Industrial Average rose Tuesday on U.S. election day. Nvidia jumped after introducing a new chip that can be exported to China.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Rallies 400 Points With Election Results, Inflation Data On Deck; Tesla Hits New Low

Dow Jones futures were little changed ahead of U.S. election results. Inflation data, including the Consumer Price Index, is due later this week.

Investors Business Daily

Dow Jones Rises 100 Points, But Apple Falls On iPhone Warning

The Dow Jones Industrial Average rose Monday, but Apple stock fell after the tech giant warned of iPhone 14 Pro production woes.

Newcastle Herald

The COVID drug under a cloud that made billions

'It's a big deal because the Australian government purchased a huge amount of that drug.'

Investors Business Daily

Dow Jones Rallies After Jobs Report; Block, Coinbase, DoorDash, Starbucks Jump On Earnings

The Dow Jones Industrial Average rallied 350 points Friday after the Labor Department's pivotal October jobs report.

Investors Business Daily

Dow Jones Falls After Jobless Claims; Roku Dives On Earnings; Jobs Report Next

The Dow Jones Industrial Average dropped Thursday amid jobless claims numbers and other key economic data. Roku stock dived on earnings.

Investors Business Daily

Dow Jones Falls Ahead Of Fed Decision, Powell Comments; AMD Rallies On Earnings

The Dow Jones Industrial Average fell Wednesday ahead of the Federal Reserve's interest rate decision, along with Fed Chair Powell's comments.

StockNews.com

This Health Care Stock Is a No-Brainer Buy for Fall

Merck & Co.’s (MRK) third-quarter financials surpassed Wall Street’s expectations. The stock is trading near its 52-week high of $101.50, and its momentum is expected to continue, considering its strong fundamentals. Given the company’s solid growth, reliable dividend payments, and the resilience of its sector against the expected economic slowdown,…

1 … 11 12 13 14

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.